Skip to main content
SpringerLink
Log in

Profile of Nucleotide Catabolism and Ectonucleotidase Expression from the Hippocampi of Neonatal Rats After Caffeine Exposure

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Nucleotides and nucleosides play an important role in neurodevelopment acting through specific receptors. Ectonucleotidases are the major enzymes involved in controlling the availability of purinergic receptors ligands. ATP is co-released with several neurotransmitters and is the most important source of extracellular adenosine by catabolism exerted by ectonucleotidases. The main ectonucleotidases are named NTPDases (1–8) and 5′-nucleotidase. Adenosine is a powerful modulator of neurotransmitter release. Caffeine blocks adenosine receptor activity as well as adenosine-mediated neuromodulation. Considering the susceptibility of the immature brain to caffeine and the need for correct purinergic signaling during fetal development, we have analyzed the effects of caffeine exposure during gestational and lactational periods on nucleotide degradation and ectonucleotidase expression from the hippocampi of 7-, 14- and 21-days-old rats. Nucleotides hydrolysis was assessed by colorimetric determination of inorganic phosphate released. Ectonucleotidases expression was performed by RT-PCR. ATP and ADP hydrolysis displayed parallel age-dependent decreases in both control and caffeine-treated groups. AMP hydrolysis increased with caffeine treatment in 7-days-old rats (75%); although there was no significant difference in AMP hydrolysis between control (non caffeine-treated) rats and 14- or 21-days caffeine-treated rats. ADP hydrolysis was not affected by caffeine treatment. Caffeine treatment in 7- and 14-days-old rats decreased ATP hydrolysis when compared to the control group (19% and 60% decrease, respectively), but 21-days-treated rats showed an increase in ATP hydrolysis (39%). Expression levels of NTPDase 1 and 5 decreased in hippocampi of caffeine-treated rats. The expression of 5′-nucleotidase was not affected after caffeine exposure. The changes observed in nucleotide hydrolysis and ectonucleotidases expression could promote subtle effects on normal neural development considering the neuromodulatory role of adenosine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190(1):S8–S21

    Article  PubMed  CAS  Google Scholar 

  2. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83–133

    PubMed  CAS  Google Scholar 

  3. Herrick-Davis K, Chippari S, Luttinger D, Ward SJ (1989) Evaluation of adenosine agonists as potential analgesics. Eur J Pharmacol 162(2):365–369

    Article  PubMed  CAS  Google Scholar 

  4. Costa MS, Botton PH, Mioranzza S, Souza DO, Porciúncula LO (2008) Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice. Neuroscience 153(4):1071–1078

    Article  PubMed  CAS  Google Scholar 

  5. Takahashi RN, Pamplona FA, Prediger RD (2008) Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies. Front Biosci 13:2614–2632

    Article  PubMed  CAS  Google Scholar 

  6. Black AM, Pandya S, Clark D, Armstrong EA, Yager JY (2008) Effect of caffeine and morphine on the developing pre-mature brain. Brain Res 1219:136–142

    Article  PubMed  CAS  Google Scholar 

  7. Zimmerberg B, Carr KL, Scott A, Lee HH, Weider JM (1991) The effects of postnatal caffeine exposure on growth, activity and learning in rats. Pharmacol Biochem Behav 39(4):883–888

    Article  PubMed  CAS  Google Scholar 

  8. Da Silva RS, Hoffman A, Souza DO, Lara DR, Bonan CD (2005) Maternal caffeine intake impairs MK-801-induced hyperlocomotion in young rats. Eur J Pharmacol 509(2–3):155–159

    Article  PubMed  Google Scholar 

  9. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2007) Long-term effects of caffeine therapy for apnea of prematurity. New Eng J Med 357(19):1893–1902

    Article  PubMed  CAS  Google Scholar 

  10. Aliyu MH, Wilson RE, Zoorob R, Brown K, Alio AP, Clayton H, Salihu HM (2009) Prenatal alcohol consumption and fetal growth restriction: potentiation effect by concomitant smoking. Nicotine Tobacco Res 11(1):36–43

    Article  Google Scholar 

  11. Millar D, Schmidt B (2004) Controversies surrounding xanthine therapy. Semin Neonatol 9:239–244

    Article  PubMed  Google Scholar 

  12. Adén U, Herlenius E, Tang LQ, Fredholm BB (2000) Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatric Res 48(2):177–183

    Article  Google Scholar 

  13. Léon D, Albasanz JL, Ruíz MA, Fernandéz M, Martín M (2002) Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J Neurochem 82:625–634

    Article  PubMed  Google Scholar 

  14. Johansson B, Ahlberg S, van der Ploeg I, Brené S, Lindefors N, Persson H, Fredholm BB (1993) Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain. Naunyn-Schmiedeberg’s Arch Pharmacol 347:407–414

    Article  CAS  Google Scholar 

  15. León D, Albasanz JL, Ruíz MA, Martín M (2005) Chronic caffeine or theophylline intake during pregnancy inhibits A1 receptor function in the rat brain. Neuroscience 131:481–489

    Article  PubMed  Google Scholar 

  16. Rivkees SA, Zhao Z, Porter G, Turner CP (2001) Influences of adenosine on the fetus and newborn. Mol Genet Metab 74:160–171

    Article  PubMed  CAS  Google Scholar 

  17. Turner CP, Yan H, Schwartz M, Othman T, Rivkees SA (2002) A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport 13:1199–1204

    Article  PubMed  CAS  Google Scholar 

  18. Zimmermann H (2001) Ecto-nucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44–56

    Article  CAS  Google Scholar 

  19. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32(1):19–29

    Article  PubMed  CAS  Google Scholar 

  20. Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113–128

    Article  PubMed  CAS  Google Scholar 

  21. Braun N, Sévigny J, Mishra SK, Robson SC, Barth SW, Gerstberger R, Hammer K, Zimmermann H (2003) Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur J Neurosci 17(7):1355–1364

    Article  PubMed  Google Scholar 

  22. Langer D, Ikehara Y, Takebayashi H, Hawkes R, Zimmermann H (2007) The ectonucleotidases alkaline phosphatase and nucleoside triphosphate diphosphohydrolase 2 are associated with subsets of progenitor cell populations in the mouse embryonic, postnatal and adult neurogenic zones. Neuroscience 150(4):863–879

    Article  PubMed  CAS  Google Scholar 

  23. Stanojevic I, Bjelobabab I, Nedeljkovicc N, Drakulica D, Petrovica S, Stojiljkovicb M, Horvat A (2011) Ontogenetic profile of ecto-5′-nucleotidase in rat brain synaptic plasma membranes. Int J Dev Neurosci 29:397–403

    Article  PubMed  CAS  Google Scholar 

  24. Bruno AN, Bonan CD, Wofchuk ST, Sarkis JJ, Battastini AMO (2002) ATP diphosphohydrolase (NTPDase 1) in rat hippocampal slices and effect of glutamate on the enzyme activity in different phases of development. Life Sci 71(2):215–225

    Article  PubMed  CAS  Google Scholar 

  25. Acquas E, Tanda G, Di Chiara G (2002) Differencial effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naïve and caffeine-preteated rats. Neuropsychopharmacology 27:182–193

    Article  PubMed  CAS  Google Scholar 

  26. Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22(15):6321–6324

    PubMed  CAS  Google Scholar 

  27. Da Silva RS, Bruno AN, Battastini AMO, Sarkis JJF, Lara DR, Bonan CD (2003) Acute caffeine treatment increases extracellular nucleotide hydrolysis from rat striatal and hippocampal synaptosomes. Neurochem Res 28(8):1273–1278

    Article  Google Scholar 

  28. Chan K, Delfert D, Junguer KD (1986) A direct colorimetric assay for Ca 2-ATPase activity. Anal Biochem 157:375–380

    Article  PubMed  CAS  Google Scholar 

  29. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:218–254

    Article  Google Scholar 

  30. Oses JP, Viola GG, de Paula Cognato G, Júnior VH, Hansel G, Böhmer AE, Leke R, Bruno AN, Bonan CD, Bogo MR, Portela LV, Souza DO, Sarkis JJ (2007) Pentylenetetrazol kindling alters adenine and guanine nucleotide catabolism in rat hippocampal slices and cerebrospinal fluid. Epilep Res 75(2–3):104–111

    Article  CAS  Google Scholar 

  31. Bona E, Adén U, Fredholm BB, Hagberg H (1995) The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate. Pediatr Res 38(3):312–318

    PubMed  CAS  Google Scholar 

  32. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Smoking, alcohol, and coffee consumption preceding Parkinson’s disease: a case-control study. Neurology 55(9):1350–1358

    PubMed  CAS  Google Scholar 

  33. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. J Am Med Assoc 283(20):2674–2679

    Article  CAS  Google Scholar 

  34. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian study of health and aging. Am J Epidem 156(5):445–453

    Article  Google Scholar 

  35. Dall’Igna OP, Porciúncula LO, Souza DO, Cunha RA, Lara DR (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol 138(7):1207–1209

    Article  PubMed  Google Scholar 

  36. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142(4):941–952

    Article  PubMed  CAS  Google Scholar 

  37. Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutri 46(2):101–123

    Article  CAS  Google Scholar 

  38. Ritchie K, Carrière I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: a prospective population study (the three city study). Neurology 69(6):536–545

    Article  PubMed  CAS  Google Scholar 

  39. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova A, Pezzola A, Regio R, Muller CE, Fuxe K, Goldberg SR, Popoli P, Ferre S (2003) Involvement of adenosine A1 and A2a receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsichopharmacology 28(7):1281–1291

    Article  CAS  Google Scholar 

  40. Noschang CG, Krolow R, Pettenuzzo LF, Avila MC, Fachin A, Arcego D, von Pozzer Toigo E, Crema LM, Diehl LA, Vendite D, Dalmaz C (2009) Interactions between chronic stress and chronic consumption of caffeine on the enzymatic antioxidant system. Neurochem Res 34(9):1568–1574

    Article  PubMed  CAS  Google Scholar 

  41. Da Silva RS, Richetti SK, Da Silveira VG, Battastini AM, Bogo MR, Lara DR, Bonan CD (2008) Maternal caffeine intake affects acetylcholinesterase in hippocampus of neonate rats. Int J Dev Neurosci 26(3–4):339–343

    Article  PubMed  Google Scholar 

  42. Gasior M, Jaszyna M, Peters J, Goldberg SR (2000) Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. J Pharmacol Exp Therap 295(3):1101–1111

    CAS  Google Scholar 

  43. Zhang LI, Poo MM (2001) Electrical activity and development of neural circuits. Nat Neurosci 4:1207–1214

    Article  PubMed  CAS  Google Scholar 

  44. Neary JT (1996) Trophic actions of extracellular ATP on astrocytes, synergistic interactions with fibroblast growth factors and underlying signal transduction mechanisms. Ciba Found Symp 198:130–139

    PubMed  CAS  Google Scholar 

  45. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purine in neurons and glial cells. Prog Neurobiol 59(6):663–690

    Article  PubMed  CAS  Google Scholar 

  46. Nedeljkovic N, Banjac A, Horvat A, Stojiljkovic M, Nikezic G (2005) Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex. Int J Dev Neurosci 23:45–51

    Article  PubMed  CAS  Google Scholar 

  47. Li W, Dai S, An J, Li P, Chen X, Xiong R, Liu P, Wang H, Zhao Y, Zhu M, Liu X, Zhu P, Chen JF, Zhou Y (2008) Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model. Neuroscience 151(4):1198–1207

    Article  PubMed  CAS  Google Scholar 

  48. Queiroz G, Meyer DK, Meyer A, Starke K, von Kugelgen I (1999) A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91:1171–1181

    Article  PubMed  CAS  Google Scholar 

  49. Sneddon P, Burnstock G (1984) ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 106(1):149–152

    Article  PubMed  CAS  Google Scholar 

  50. Weaver DR (1996) A1—adenosine receptor gene expression in fetal rat brain. Dev Brain Res 94:205–223

    CAS  Google Scholar 

  51. Desfrere L, Olivier P, Schwendimann L, Catherine V, Gressens P (2007) Transient inhibition of astrocytogenesis in developing mouse brain following postanatal caffeine exposure. Pediatric Res 62(5):604–609

    Article  CAS  Google Scholar 

  52. Heyliger CE, Panagia V, Dhalla NS (1981) Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5′-nucleotidase. J Pharmacol Exp Therap 217(2):489–493

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by CNPq (Conselho Nacional de Pesquisa e Desenvolvimento – Brasil), Fundação de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and by the FINEP research grant “Rede Instituto Brasileiro de Neurociência (IBN-Net)” 01.06.0842-00.

Author information

Authors and Affiliations

  1. Laboratório de Neuroquímica e Psicofarmacologia, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga, 6681, Porto Alegre, RS, Brazil

    R. S. Da Silva, S. K. Richetti, E. M. Tonial & C. D. Bonan

  2. Laboratório de Biologia Genômica e Molecular, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil

    M. R. Bogo

Authors
  1. R. S. Da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Richetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. M. Tonial
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. R. Bogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. D. Bonan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. S. Da Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Da Silva, R.S., Richetti, S.K., Tonial, E.M. et al. Profile of Nucleotide Catabolism and Ectonucleotidase Expression from the Hippocampi of Neonatal Rats After Caffeine Exposure. Neurochem Res 37, 23–30 (2012). https://doi.org/10.1007/s11064-011-0577-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-011-0577-0

Keywords

Search

Navigation